Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce ...

MedCity News Editor in Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch, also discussed ...

The government shutdown is drawing backlash from healthcare leaders over its potential to disrupt ACA subsidies, Medicare ...

Market conditions continue to pose challenges for startups trying to raise money. Some of these companies might be a fit for Sanofi’s corporate venture capital arm, which the pharmaceutical giant has ...

Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar acquisition of Metsera, a clinical-stage company whose ...

The White House released “America’s AI Action Plan” last week, which outlines various federal policy recommendations designed to advance the nation’s status as a leader in international AI diplomacy ...

Capital Rx, a transparent pharmacy benefit manager, has secured a $400 million investment and is rebranding under the name Judi Health as it expands beyond pharmacy benefits, the company announced on ...

The world’s tech giants continue to go after strategic acquisitions aimed at deepening their presence in the healthcare world. On Tuesday, Samsung announced its plans to acquire Xealth, a digital ...

Many providers express confidence about their AI strategy, but relatively few have established the governance structures needed to ensure responsible AI deployment, according to new research. Nordic ...

Although most healthcare organizations are strengthening their cybersecurity efforts, serious vulnerabilities still persist, according to research released this week by Fortified Health Security, a ...